Human endogenous retrovirus K Rec forms a regulatory loop with MITF that opposes the progression of melanoma to an invasive stage by Singh, M. et al.
 1 of 23 
Singh et al. (2020) 
Article 1 
Human Endogenous Retrovirus K Rec forms a 2 
regulatory loop with MITF that opposes the 3 
progression of melanoma to an invasive stage 4 
Manvendra Singh1,2#, Huiqiang Cai1#, Mario Bunse1, Cedric Feschotte2 and Zsuzsanna Izsvák*1 5 
1 Max-Delbrück-Center for Molecular Medicine (MDC), in the Helmholtz Society Robert-Rössle-Strasse 10, 6 
13125 Berlin, Germany  7 
2  Department of Molecular Biology & Genetics, 526 Campus Road, Cornell University, Ithaca, NY 14853 8 
# Equal Contributions 9 
* Correspondence: 10 
Abstract: In the human genome, HERV-K(HML2) is the most recently endogenized retrovirus 11 
(ERV). While HERV-K(HML2) transcription is observed in healthy tissues, various cancers showed 12 
the upregulation of retroviral derived endogenized accessory products (e.g., envelope (Env), Np9 13 
and Rec). Still, it is not clear whether the different HERV-K-derived genes contribute to a disease, 14 
or they are mere by-products. Here, we focus on the potential role of Rec in melanoma. Our in vitro 15 
model and high throughput data mining, including single-cell transcriptome analyses of patent's 16 
material, reveal that Rec expression marks the proliferative (still controllable) stage of melanoma, 17 
and is involved in maintaining a delicate balance between cell proliferation and invasion. Thus, 18 
similar to melanocyte-inducing transcription factor (MITF), Rec is a sensitive marker of melanoma 19 
progression. Our Rec-knockdown in vitro system can faithfully model a subpopulation (MITF 20 
malignancy) of melanoma cells in human patients. Like Env, Rec modulates an endothelial-21 
mesenchymal transition (EMT)-like process of cancer progression; however, they seem to affect the 22 
phenotype switch inversely. Rec inhibits the transition to the invasive state by altering the 23 
expression level of some key determinants of the EMT-like process, including MITF that directly 24 
binds the LTR5 _Hs of HERV-K. The Hominoid-specific HERV-K products might explain certain 25 
species-specific features of melanoma progression, and pinpoint to the limitation of using animal 26 
models in melanoma studies. 27 
Keywords: HERV-K, Rec, Melanoma, Metastasis, and MITF 28 
 29 
1. Introduction 30 
Endogenous retroviruses (ERVs) are remnants of retroviruses that once infected the germline 31 
and became vertically inherited as part of the host genome. Sequences derived from various ERVs 32 
account for 8% of the human genome [1], reflecting multiple waves of retroviral invasion in the 33 
human lineage. In the human genome, HERV-K(HML2) is the most recently endogenized HERV, and 34 
several copies of this subgroup still express retroviral open reading frames (e.g., Gag, Pro-Protease, 35 
Pol-Polymerase, Env-Envelope), and are even capable of producing (non-infective) viral particles [3]. 36 
The canonical function of HERV-K Env is to enable the retrovirus to traffic through the endosomal 37 
membrane of the host cells or directly enter cells by fusing with their membranes. The endogenization 38 
process of HERV-K(HML2) (HERV-K thereafter) included the emergence of the accessory proteins, 39 
Np9 and Rec, translated from splicing products of the Env mRNA [3, 4]. Env, Np9, and Rec interact 40 
with different host-encoded cellular factors and have distinct functional activities. Rec is a small 41 
RNA-binding protein considered to be a functional homolog of the HIV Rev accessory protein [5]. 42 
Through its interaction with the CRM1 nuclear export factor [4, 6], Rec is involved in exporting un-43 
spliced HERV-K RNA from the nucleus [3, 7]. Also, Rec can directly modulate cell signaling via 44 
binding to the promyelocytic leukemia zinc finger (PLZF) protein, a transcriptional repressor of the 45 
c-MYC proto-oncogene [8]. Rec also binds the TZFP (testicular zinc-finger protein) and the hSGT 46 
(human small glutamine-rich tetratricopeptide repeat protein), which are transcriptional repressors 47 
.CC-BY-NC-ND 4.0 International license(which was not certified by peer review) is the author/funder. It is made available under a
The copyright holder for this preprintthis version posted June 2, 2020. . https://doi.org/10.1101/2020.05.27.120170doi: bioRxiv preprint 
 2 of 23 
Singh et al. (2020) 
of the androgen receptor [9, 10]. While it is evident that Rec must have first evolved to facilitate 48 
HERV-K replication, there is speculation that the protein may have been coopted for physiological 49 
function, such as spermatogenesis [6, 11] and defense against viral infections in the early human 50 
embryo [12]. 51 
It has been reported that at least 18 HERV-K genomic loci can be transcribed in healthy human 52 
tissues and express potentially-coding Rec or Np9 mRNAs (alone or in combination with retroviral 53 
genes). However, the landscape of transcribed HERV-K loci differs considerably between cell/tissue 54 
types [13]. Rec RNA/protein expression has been observed in human embryonic tissues, placenta, 55 
and retina [14, 15]. Interestingly, HERV-K is expressed in both germinal- and pluripotent stem cells, 56 
providing a particular link between these cell types [16]. While HERV-K transcription has been 57 
observed at low levels in various healthy tissues, it is strongly induced upon environmental stress, 58 
such as ultraviolet irradiation (e.g., UVB and UVC), starvation, or viral infection that may manifest 59 
the global DNA hypomethylation [17-21]. Furthermore, many studies have reported robust mRNA 60 
upregulation of several genomic loci of HERV-K in various disease states, including certain 61 
autoimmune diseases and several cancers, especially lung, breast cancers, germ cell tumors, and 62 
melanoma [18, 22, 23] and reviewed in [24, 25]. Moreover, transcriptional activation and translation 63 
of various HERV-K products [22, 26] and even virus-like particles have been observed in specific 64 
cancer cells such as teratoma, embryonic carcinoma, and melanomas [3, 27-29]. 65 
Whether and how the overexpression of HERV-K products contributes to the progression of 66 
these diseases is the subject of many studies, debates, and speculations. Several mechanisms have 67 
been proposed by which HERV-K might contribute to disease. The activated LTRs could act as 68 
alternative promoters and de-regulate tumor suppressor genes or proto-oncogenes (reviewed in [35, 69 
36]). Furthermore, the Env protein of HERV-K, via its fusogenic property, is capable of inducing cell-70 
cell fusion and could, therefore, contribute to tumor invasiveness [18, 37, 38]. Env could also have 71 
oncogenic properties through direct interference with cellular signaling pathways (e.g., 72 
RSS/MEK/ERK) [39, 40]. Indeed, the overexpression of the HERV-K Env protein has been reported 73 
to induce an epithelial to mesenchymal transition (EMT)-like process [39, 41], a crucial event in 74 
oncogenesis leading to a more malignant phenotype. In addition, Env was suggested to promote 75 
tumorigenesis via modulation of the immune response [42-44]. Confusingly, HERV-K may have 76 
either a positive or negative effect on the immune system [45, 46]. Similar to Env, the expression of 77 
the accessory genes, Rec and Np9 were readily increased in pathological conditions [47], including 78 
germ cell tumors and melanoma [4, 6, 22, 27, 28, 48-52]. Still again, it was not clear whether and how 79 
these factors could contribute to tumorigenesis and other disease states. 80 
To begin answering this question, we investigate the oncogenic properties of HERV-K Rec (Rec 81 
thereafter) in melanoma. We used in vitro models as well as high throughput data mining, including 82 
single-cell transcriptome analyses of patient samples, to examine the impact of Rec expression in the 83 
spatiotemporal progression of melanoma. We found that Rec marks the proliferative state of 84 
melanoma, and similarly to Env [39], modulates the EMT-like process of cell transformation. 85 
However, surprisingly, in contrast to Env [39], Rec is inhibiting and not activating the transition from 86 
proliferative to invasive state and thus might be, in fact, a protective factor in melanoma. 87 
2. Materials and Methods  88 
2.1. Construction of the KD constructs 89 
All 3 KD targeting the ERVK6(HML2.HOM) locus. KD1 targets 3'UTR, KD2 3'UTR, and KD3 the 90 
gene body of Rec.  91 
KD1 construct 1 (3'UTR_I): (as) 5-'ATCCATTCAACTCTGAGTGGA-3' 92 
KD2 construct 2 (5'UTR_I): (as) 5'-TAAGGCTGACTGTAGATGTAC-3' 93 
KD3 construct 4 (Rec): (as) 5'-CAACGGTGCTCGATTGCGATG-3' 94 
2.2. Cell Culture 95 
The melanoma cell line, A375 (ATCC CRL-1619) was cultivated in RPMI1640 (Thermo Fisher 96 
Scientific) supplemented with 10% fetal bovine serum (FBS; PAA Laboratories, Pasching, Austria), 97 
80 U/mL penicillin and streptomycin (Lonza, Basel, Switzerland) at 37°C in a humidified atmosphere 98 
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of 95% air and 5% CO2. The melanoma cell line, SKMel-28 (ATCC HTB-72) was maintained in 99 
Dulbecco's modified Eagle's medium (DMEM, Life Technologies, England) containing GlutaMAX™-100 
I supplement (Gibco, catalog number: 31966-021), with 10% FBS and penicillin and streptomycin in 101 
the same condition as above.  102 
2.3. Transfection of melanoma cells and cell sorting 103 
To knock down Rec, melanoma cells were transfected with pT2-MP71-KD1-Rec-EGFP, pT2-104 
MP71-KD2-Rec-EGFP, pT2-MP71-KD3-Rec-EGFP plasmids in the presence of pT2-CAGGS-SB100X, 105 
using the Neon transfection system (Life technologies). A piggyBac transposon-based vector, 106 
targeting GFP, was used as a control. 10µl Kit with the electroporation setting, 1350 V (pulse voltage), 107 
20ms (pulse width), two pulses. 2×105 cells in 11 µL resuspension buffer R were combined with 2 µL 108 
of purified plasmid mixture (50 ng transposase and 500 ng transposon). Transfected cells were 109 
transferred to 6-well tissue culture plates containing 2 mL culture medium. EGFP+ cells were sorted 110 
at weeks 1 and 3 post-transfection by FACSAria II cell sorter (Becton). 111 
2.4. Quantitative Real-Time PCR and semi-quantitative PCR 112 
Total RNA was extracted using the Direct-zol RNA MiniPrep kit (Zymo Research) according to 113 
the protocol of the manufacturer. Reverse transcription was performed from 1µg total RNA with the 114 
High Capacity RNA-to-cDNA kit (Applied Biosystems). The isolated RNA would be treated with 115 
additional DNaseI (Invitrogen), to get rid of potential DNA contamination. Quantitative real-time 116 
PCR (qRT-PCR) was carried out on ABI7900 with PowerUp SYBR Green Master Mix kit (Applied 117 
Biosystems), according to the recommendations of the manufacturer. For quantification of mRNA 118 
expression levels, real-time PCR was run in triplicates for each cDNA sample, using GAPDH and 18s 119 
RNA as the internal controls for SKMel-28 and A375 cells, respectively, for primers and annealing 120 
temperatures see Table 1.  Data were analyzed using the comparative CT (2-∆∆CT) method, which 121 
describes relative gene expression.  122 
Table 1. The primers/oligos used in this study. 123 
Name Application Sequence (5' – 3') Tm(°C) 
HML-2-Env Real-Time qPCR 
F: GCTGCCCTGCCAAACCTGAG 
R: CCTGAGTGACATCCCGCTTACC 
60 
HML-2-Gag Real-Time qPCR 
F: AGCAGGTCAGGTGCCTGTAACATT 
R: TGGTGCCGTAGGATTAAGTCTCCT 
60 
HML-2-Np9 Real-Time qPCR 
F: AGATGTCTGCAGGTGTACCCA 
R: CTCTTGCTTTTCCCCACATTTC 
60 
HML-2-Rec Real-Time qPCR 
F: ATCGAGCACCGTTGACTCACAAGA 
R: GGTACACCTGCAGACACCATTGAT 
60 
MITF-M Real-Time qPCR 
F:ATGCTGGAAATGCTAGAATATAATCACT 
R: GAATGTGTGTTCATGCCTGG 
60 
SPANXB1/B2 Real-Time qPCR 
F: AGGCCAATGAGGCCAACAAGAC 
R: TCCTCCTGTAGCGAACCACTAG 
60 
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18S RNA Real-Time qPCR 
F: GTAACCCGTTGAACCCCATT 
R: CCATCCAATCGGTAGTAGCG  
60 
GAPDH Real-Time qPCR 
F: CAATGACCCCTTCATTGACCTC 
R: AGCATCGCCCCACTTGATT 
60 
2.5. RNA sequencing and data analysis  124 
The concentration of RNA was measured on NanoDrop Spectrophotometer ND-1000, and the 125 
quality of RNA was analyzed using Agilent RNA 6000 Nano Kit on Aligent 2100 Bioanalyzer 126 
machine. The RNA sequencing library was prepared from 550 ng of RNA, using Illumina TruSeq 127 
Stranded mRNA LT Set A kit (Cat. no. RS-122-2101), according to TruSeq Stranded mRNA Sample 128 
Prep LS Protocol. Sequencing was performed on an Illumina HiSeq 2000 platform as 100 bp first 129 
strand-specific paired-end reads. 130 
Sample-specific barcoded sequencing reads were de-multiplexed from multiplexed flow cells 131 
and by using CASAVA. 1.8.2 BCL files were converted to FASTQ format files. The quality of the raw 132 
sequence reads was determined by using the FastQC. Reads with a quality score below 30 were 133 
removed. We removed the highly variable two nt from the ends of the remaining sequencing reads 134 
and mapped them over the reference genome (Human hg19/GRCh37) and transcriptome model 135 
(hg19.refseq.gtf). hg19/GRCh37 and hg19.refseq.gtf that were downloaded from USCS tables 136 
(http://hgdownload.cse.ucsc.edu/goldenPath/hg19/bigZips/) by using Bowtie 2.0.5.0, Samtools 137 
0.1.17.0 and TopHat v2.0.8 with parameters: “tophat2 -p 8 –r 150--mate-std-dev 140 --library-type fr-138 
first-strand”. Transcript assembly for each sample was conducted with Cufflinks v2.08, generating 139 
FPKM values. In the cross-study or/and cross-platform comparisons, we normalized the batch effect 140 
using the 'combat' package from R. Differentially expressed genes (DEGs) were calculated as counts 141 
per million (CPM) using featureCount and algorithms from "DESeq2". This strategy provided both 142 
quantification and statistical inference of systematic changes between conditions (with at least three 143 
replicates). We had generated various transcriptomes from A375 cells (e.g., A375-untransfected, 144 
A375-scambled transfection control, A375-knockdowns targeting HERV-K(HML2) Rec using three 145 
distinct RNAi constructs, Rec-KD1,2,3). We performed similar studies in SK-MEL28 cell lines. As an 146 
additional control, and to increase statistical power for DEGs identified in our transcriptomes upon 147 
Rec-KD, we also used publicly available A375 RNA-seq datasets (GSE110948). To analyze single-148 
replicate RNA-seq datasets, we utilized the "GFOLD" algorithm for normalization, which calculates 149 
a variance of fold-changes from unreplicated RNA-seq data. Canonical pathways and biological 150 
function of the differentially expressed genes (DEGs) were further subjected to KEGG and Gene Set 151 
Enrichment Analyses (GSEA). 152 
2.6. Single-cell RNA-seq data processing 153 
We got the single-cell count matrix from GSE72056. We calculated the activity of genes in every 154 
cell at TPM expression levels. We considered samples expressing over 1000 genes with expression 155 
levels exceeding the defined threshold (Log2 TPM > 1). We used Seurat_3.1.1, a package from R to 156 
normalize the datasets at the logarithmic scale using "scale.factor = 10000”. After normalization, we 157 
calculated scaled expression (z-scores for each gene) for downstream dimension reduction. We used 158 
the original annotations of datasets to classify the malignant, non-malignant, and heterogenous cell-159 
types.  To define cell population clusters, we employed the FindClusters function of "Seurat" using 160 
"PCA" as a reduction method.  The specific markers for each cluster identified by "Seurat" were 161 
determined by the "FindAllMarkers" function, using "roc" as a test for significance. This provided us 162 
two lists of gene sets, 1) Malignant vs. Non-Malignant differentially expressed genes and 2) genes 163 
differentially expressed between MITF-High and MITF-low tumors, which we applied for comparing 164 
the DEGs from Rec-KD RNA-seq. Feature plots, violin plots, and heatmaps were constructed using 165 
default functions, except for the color scale that was set manually. The annotated cells were re-166 
clustered using the methodologies described above and visualized on the UMAP coordinates. 167 
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2.7. ATAC-seq and ChIP-seq data analyses 168 
ATAC-seq and ChIP-seq raw datasets in sra format were downloaded from the listed studies 169 
and converted to fastq format using sratools function fastq-dump –split-3. Fastq reads were mapped 170 
against the hg19 reference genome with the bowtie2 parameters: --very-sensitive-local. All 171 
unmapped reads with MAPQ < 10 and PCR duplicates were removed using Picard and samtools. All 172 
the ATAC-seq peaks were called by MACS2 with the parameters –nomodel -q 0.01 -B. Blacklisted 173 
regions were excluded from called peaks 174 
(https://www.encodeproject.org/annotations/ENCSR636HFF/). To generate a set of unique peaks, 175 
we merged ATAC-seq peaks using the mergeBed function from bedtools, where the distance between 176 
peaks was less than 50 base pairs. We then intersected these peak sets with repeat elements from hg19 177 
repeat-masked coordinates using bedtools intersectBed with a 50% overlap. To calculate the 178 
enrichment over the given repeat elements, we first extended 5KB upstream and 5KB downstream 179 
coordinates from the left boundary (TSS) of respective elements in a strand-specific manner. These 180 
10KB windows were further divided into 100 bps bins, and tags (bedGraph output from MACS2) 181 
were counted in each bin. Tag counts in each bin were normalized by the total number of tags per 182 
million in given samples and presented as Counts Per Million (CPM) per 100 bps. We averaged CPM 183 
values for each bin between replicates before plotting the figures.  To find the MITF binding motifs, 184 
25 bps sequences were extended from either side of ChIP-seq peak summits. The extended sequences 185 
were analyzed by the RSAT tool (http://rsat.sb-roscoff.fr/). The TF binding motifs were calculated 186 
from JASPAR libraries of human TF motifs. 187 
2.8. Cell invasion assay 188 
The cell invasion assays were performed using transwell chambers (8 #m pore size; Corning 189 
Costar) according to the vendor's instructions. Briefly, the insert of the wells was first coated with 50 190 
#l BD matrigel. A375 cells were resuspended with RPMI1640 medium containing 0.5% FCS to reach 191 
a concentration of 5×105 cells/ml. Then 100 #l cells from each group were seeded into the upper 192 
chamber of the insert, with adding DMEM containing 10% FCS to the lower chamber. After 193 
incubation at 37 °C in a humidified atmosphere of 5% CO2 for 24 h, non-invaded cells were removed 194 
with gentle swabbing while the invaded ones were stained. Then images were taken with 195 
microscopy. Cell numbers were calculated with ImageJ.  196 
2.9. Accession of datasets used in this study: 197 
Encode chromHMM datasets: 198 
ftp://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeBroadHmm 199 
Encode TF ChiP-seq datasets: 200 
ftp://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeSydhTfbs 201 
GSE60663: H3K27Ac Primary Melanoma 202 
GSE60663: H3K4Me3 Primary Melanoma 203 
GSE60663: MITF ChIP-seq Primary Melanoma 204 
GSE60664: RNA-seq Primary Melanoma 205 
GSE110948: A375 RNA-seq 206 
GSE46817: RNA-seq of 7 distinct melanoma lines 207 
GSE46805: RNA-seq Melanocyte BRAF overexpression  208 
GSE50681: MITF ChIP-seq Melanoma and Melanocyte post-treatment 209 
GSE82330: ATAC-seq Melanoma A375 210 
GSE72056: Patient’s Single cell RNA-seq data 211 
3. Results 212 
3.1. LTR5_Hs loci form active chromatin in cancer and pluripotent cell lines  213 
The regulatory region of the youngest subfamily of HERV-K is the human-specific long terminal 214 
repeat 5 (LTR5_Hs). To dissect the regulation of HERV-K transcription in different cell types, we 215 
adopted a systematic genome-wide approach using publicly available data. For this, we investigated 216 
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the chromatin state at ~600 full-length LTR5_Hs sequences using the uniquely mappable reads in 9 217 
different cell types from the ENCODE project [50]. Analysis of the chromatin states suggested that a 218 
substantial fraction (n = 227) of LTR5_Hs sequences overlap with active or permissive chromatin 219 
states (Figure 1A). When compared to differentiated somatic cells, these LTR5_Hs genomic loci 220 
showed features of active ('open') chromatin state in human embryonic stem cells (H1_ESCs) and in 221 
cancer cell lines (Figure 1A).  222 
Various transcription factors (TFs) have been reported to bind LTR5_Hs/HERV-K, including the 223 
pluripotency factors such as OCT4 [12, 51] or the melanocyte inducing TF (MITF) [52]. In a systematic 224 
approach, we mapped the peaks from 142 ChIP-seq TF datasets from 7 cell lines (ENCODE) over 225 
LTR5_Hs genomic loci (n ~ 600). Our integrative analysis of various TF occupancy revealed that 226 
LTR5_Hs recruits significantly more TFs in H1 embryonic stem cells (H1_ESCs) and leukemia K562 227 
cells, compared with HepG2, GM12878 or HUVEC cells (Figure 1B), which may indicate elevated 228 
levels of HERV-K transcription in embryonic stem cells and cancer cells. While in H1_ESCs, LTR5_Hs 229 
was bound prominently by pluripotency specific TFs (e.g., NANOG) (Figure 1B-C), the cancer line 230 
(K562) displays the binding of multiple TFs that control the cell cycle and proliferation (e.g., c-MYC, 231 
MAX, COREST, P300, PU1, GATA2, and JUND) (Figure 1B-C and Table S1). Intriguingly, NANOG 232 
binding over LTR5_Hs is overrepresented in 3iL naïve conditions (Figure 1C). The observed HERV-233 
K virion particles in the human blastocyst might be the products of HERVK driven by NANOG [12]. 234 
The active chromatin states and TF bindings over LTR5_Hs in cancer lines might be associated with 235 
the oncogenic phenotype. 236 
3.2. MITF regulated LTR5_Hs/HERV-K expression is a hallmark of the 'proliferative' type of 237 
melanoma  238 
It has been previously reported that in melanoma, the melanocyte/melanoma-specific isoform, 239 
MITF-M may bind LTR5_Hs, and promotes the expression of HERV-K transcripts [52]. MITF(-M) is 240 
a critical transcription factor associated with melanoma progression [53, 54], and is a sensitive marker 241 
of melanoma invasiveness; highly expressed in the melanocytes and the proliferative state of 242 
melanoma (e.g., MITF-high) but lowly expressed in the invasive state (e.g., MITF-low) [55].  243 
To investigate how HERV-K is controlled in melanoma, we mined ChIP-seq and RNA-seq data 244 
from melanocytes, various melanoma cell lines, and primary melanoma cultures (Methods). 245 
Importantly, characterizing primary melanoma cultures according to their MITF levels (Figure 1D) 246 
revealed a positive correlation between MITF-regulated LTR5_Hs/HERV-K transcription and 247 
invasiveness (Figure 2A). To see if additional transposable elements (TEs) respond to melanoma 248 
proliferative/invasive status, we extended the systematic analysis over all of the TE families. This 249 
analysis revealed that the expression of certain ERVs, including LTR5_Hs/HERV-K, LTR2C, and 250 
LTR13, was correlated with proliferative melanoma associated genes (Figure S1A). Nevertheless, 251 
when compared to the overall expression of other TE families, LTR5_Hs/HERVK was the most 252 
abundantly expressed TE family and highly correlated with MITF level (rho = 0.43, corrected p-value 253 
< 0.2e-9) in the melanoma primary cultures (N=10) (Figure 2B). These data suggest that 254 
LTR5_Hs/HERV-K expression can be used as a marker that correlates negatively with melanoma 255 
invasiveness. Next, we characterized LTR5_Hs loci activated in the proliferative type of melanoma 256 
cells by layering ChIP-seq occupancy signals of H3K4Me3, H3K27Ac, and MITF (Figure 2C and S1B-257 
C). We found that MITF binding at LTR5_Hs loci coincides with the presence of the canonical E-box 258 
motif (CA(C/T)GTG), which is recognized by MITF as well as c-MYC, and MAX TFs [56] (Figure 2C).  259 
We also investigated the regulation of HERV-K transcription in the BRAFV600E mutant, an 260 
invasive type of melanoma. PLX4032, a commonly used BRAFV600E inhibitor in the clinic, enhances 261 
the expression of MITF by several folds that revert melanoma from an invasive to the proliferative 262 
state [59]. To examine how PLX4032 treatment affects HERV-K expression, we reanalyzed the 263 
publicly available MITF ChIP-seq datasets of primary melanocytes and a BRAFV600E mutant 264 
melanoma cell line (COLO829) with and without PLX4032 treatment (GSE50681). We observed that 265 
PLX4032 treatment results in a substantial enrichment of MITF ChIP-seq peaks over LTR5_Hs 266 
elements (123 unique loci were bound) (Figure 2D). When compared to other TE families, the gain of 267 
MITF binding occurred specifically over LTR5_Hs (Figure 2E). Importantly, while MITF is expressed 268 
in healthy pigmented cells, we found no elevated MITF ChIP-seq signal over LTR5_Hs elements upon 269 
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PLX4032 treatment in normal, pigmented melanocytes (Figure 2D). Thus, MITF binding to LTR5_Hs 270 
is specific to the proliferative state of melanoma.   271 
Collectively, the MITF binding may lead to LTR5_Hs activation, not typical in healthy 272 
melanocytes, but in the proliferative type of melanoma, thus can be considered as a sensitive marker 273 
of the proliferative vs. invasive phenotype of melanoma.  274 
3.3. Depleting HERV-K-Rec induces an EMT-like process in A375 melanoma cells 275 
The ERVK6 locus (located on the Chr7 p22.1) produces both retroviral ORFs (Gag and Env) and 276 
the accessory HERV-K product, Rec [13, 28]. To see how this specific locus responds to MITF in 277 
proliferative (MITF-High), invasive (MITF-Low) primary melanoma lines, we analyzed a published 278 
dataset for H3K27ac and MITF ChiP-seq (GSE60663), and also included the proliferative type A375 279 
melanoma cell line in the analysis (GSE82330). This locus showed a higher H3K27Ac signal in both 280 
proliferative MITF-High and A375 cells relative to MITF-Low cells, and also a significant ATAC-seq 281 
signal in A375 (Figure 3A), indicating that this locus is preferentially active in a proliferative type of 282 
melanoma. Moreover, ATAC-seq and active histone mark analysis (e.g., H3K27ac and H3K4Me1) 283 
support the accessibility of multiple LTR5_Hs in A375 (Figure 3B-C), suggesting that A375 cell line 284 
might be an adequate model for this type of melanoma. 285 
To decipher the underlying difference of the invasiveness of various melanoma cells and the 286 
potential role of Rec in melanoma, we first used an RNAi approach to deplete Rec expression in two 287 
melanoma cell lines (e.g., A375 and SKMel-28) of different invasiveness. A375 and SKMEL-28, both 288 
wild type for the tumor suppressor PTEN and carry the BRAFV600E mutation, but A375 have a higher 289 
proliferation rate, whereas SKMEL-28 is more invasive [62]. To knockdown (KD) Rec, we designed 290 
three RNAi constructs. These constructs were delivered using Sleeping Beauty as a stable vector [63], 291 
and also expressed a fluorescence reporter (GFP). To generate stable KD cell lines for both A375 and 292 
SKMel-28, the KD constructs were transfected together with the SB100X transposase [64]. The stable 293 
KD-Rec lines were selected in two-rounds by FACS sorting for the GFP-reporter signal. Real-time 294 
qRT-PCR showed that Rec transcript levels were strongly depleted in each of the three independent 295 
KD cell lines isolated for both A375 and SKMel-28 (Figure 3D). Notably, as a side effect, knocking 296 
down Rec also led to an increased level of alternative retroviral HERV-K transcripts, Gag and Env in 297 
SKMel-28, and A375, respectively (Figure 3E). 298 
To detect global transcriptional changes in an unbiased way, we used RNA-seq analysis of the 299 
stable KD-Rec cell lines. The study of individual HERV-K genomic loci revealed that our KD strategy 300 
(using three biological replicates) significantly affected seven Rec expressing loci in KD-Rec_A375 301 
cells (Figure 3F). SKMel-28, by contrast, has only three HERV-K loci expressing Rec (not shown) [28]. 302 
Having validated our Rec KD lines, we performed a global analysis of differentially expressed 303 
genes (DEGs) (|2|-fold and FDR < 0.05, (Figure S1E, Table S1, see Methods) between the KD lines 304 
and the parental cell lines. The list of the DEGs was different between the A375 and SKMel-28 knock-305 
downs, which could be in part explained by the distinct patterns of active HERV-K loci in the two 306 
melanoma lines. In KD-Rec_SKMel-28, DEGs (Table S1) did not include MITF and were not 307 
significantly enriched for any Gene Ontology (GO) categories, and formed no discernible pattern, 308 
suggesting that knocking-down Rec in this particular (invasive) melanoma line was not instructive 309 
of biological process alterations. The smaller number of Rec expressing HERV-K loci and the 310 
antagonistic elevation of the alternative retroviral product (e.g., Rec) in KD-Rec_SKMel-28 might, at 311 
least partially, explain the lack of distinct pattern. 312 
In contrast, GO analysis of 1120 DEGs in KD-Rec_A375 revealed that most of the dysregulated 313 
genes were associated with cell communication, followed by the cell cycle, cell proliferation (Figure 314 
4A). Narrowing down the list of DEGs by excluding genes of the category of system development, 315 
the remaining genes were enriched in clusters of cell differentiation, stem cell differentiation, cell 316 
death, and system development. Genes in the stem cell differentiation and system development 317 
categories could be linked to the WNT signaling pathway. Among DEGs in KD-Rec_A375, we 318 
identified genes involved in an epithelial-mesenchymal transition (EMT)-like process, which has 319 
been observed to play a critical role in phenotype switching in the proliferative to invasive state [33, 320 
66, 67]. Intriguingly, this set of DEGs included matrix metallopeptidase 2 (MMP2), a classical marker 321 
of cell invasion and additional four genes from the list of the 16 critical markers of the canonical EMT 322 
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process [65] (e.g. N-Cadherin (CDH2), zinc finger protein (SNAI2), forkhead box C2 (FOXC2) and 323 
goosecoid Homeobox (GSC) (Figure 4B-C). 324 
Nevertheless, as the melanocytes and melanoma cells differ from epithelial and mesenchymal 325 
cells, respectively, the EMT-like process in melanoma phenotype switching is characteristically 326 
different from the canonical EMT process [33]. In melanoma metastasis, the TF network switches to 327 
the melanoma-specific SNAI2low/ZEB2low/ZEB1high phenotype [69-71], that we also observed in our 328 
KD-Rec_A375 cells (Figure 4B-C), suggesting that Rec modulates the melanoma-specific EMT-like 329 
phenotype switching. The elevated level of EMT markers in KD-Rec_A375 cells suggests that Rec 330 
inhibits the EMT-like process. 331 
Beside canonical EMT markers, we also observed the upregulation of further factors in KD-332 
Rec_A375 cells, known to act as inducers of the EMT-like process. For example, non-canonical WNT 333 
signaling via WNT5A and GSK3B, which is markedly upregulated in KD-Rec_A375 cells (Figure 4D), 334 
is critical for the switch to an EMT-like invasive phenotype when melanoma gets relapsed [72, 73]. 335 
Furthermore, the most extensively studied inducer of EMT, TGF-β [74, 75], reported to control SNAI2 336 
[76], was also upregulated in our KD-Rec_A375 transcriptomes (Table S1). 337 
In addition, among the top DEGs, we observe a strong upregulation of several members of the 338 
SPANXC (sperm protein associated with the nucleus in the X chromosome) family of genes (Figure 339 
4D-E), which are typically expressed in the germline. The upregulation of SPANXB1/2, clinically 340 
relevant cancer-testis antigens, has been previously reported in melanoma [75] and was also 341 
validated by qRT-PCR in our KD-Rec_A375 samples (Figure 4E). Simultaneous upregulation of 342 
multiple genes physically located within the SPANX (B/C) chromosomal cluster suggests an 343 
epigenetic disturbance affecting the entire locus. Indeed, the epigenetically sensitive Polycomb 344 
repressor complex 2 (PRC2) has been implicated in maintaining SPANXB in a transcriptionally silent 345 
state in differentiated cells [76]. Our data suggest that Rec may exert directly or indirectly an effect 346 
on the epigenome of melanoma, an aspect that we did not follow up in this study. 347 
Importantly, in our KD-Rec_A375 cells, we detected a robust transcriptional decrease in the level 348 
of MITF-M, the governor of the melanocyte differentiation program (Figure 5A), confirmed by qPCR. 349 
In addition to MITF, we observed a decreased expression of further melanocyte differentiation 350 
markers (e.g., TYR, PMEL) [77] (Figure 5B).  351 
Collectively, our transcriptome analysis in KD-Rec_A375 cells suggests that Rec might function 352 
as a cellular factor inhibiting the melanoma phenotype switching to the invasive state. 353 
 354 
3.4. Rec is a suppressor of cell invasion in melanoma 355 
Our SNAI2low/ZEB2low/ZEB1high phenotype, attributed to aggressive melanoma, suggested that 356 
knocking down Rec, via induction of an EMT-like process, might affect the invasiveness of A375 cells. 357 
Further on this line, the decreased level of MITF, and the transcriptome-wide DEGs of invasive vs. 358 
proliferative melanoma markers also predicted enhanced invasiveness of KD-Rec_A375 cells. To test 359 
these predictions, we performed a trans-well invasion assay to compare the invasiveness of KD-360 
Rec_A375 cells to their parental line. The results showed that all three KD-Rec_A375 lines exhibited 361 
significantly elevated invasiveness (Figure 5C-D). The enhanced metastatic potential of the 362 
melanoma upon Rec KD supported the idea that Rec functions as a suppressor of the EMT-like 363 
transition process, which modulates the invasiveness of melanoma. 364 
3.5. The KD-Rec_A375 in vitro model mimics the MITF type malignancy in patients  365 
Next, we sought to examine whether some of the genes dysregulated upon Rec KD in A375 cells 366 
were also differentially regulated in malignant cell types. To assess this, and to monitor the dynamics 367 
of Rec-regulated genes in the progression of tumors, we performed a single comprehensive cell 368 
(sc)RNA-seq analysis (n=4645) derived from melanoma patients (n=19) [78]. Congruent with the 369 
original study [78], our analysis with default parameters from the 'Seurat' algorithm distinguishes 370 
clusters of non-malignant and malignant cell types (Figure 6A). The five distinct malignant cell types 371 
were marked by high expression levels of MAGEC2, MITF, APOE, VIM, and SPP1, respectively 372 
(Figure 6A-B).  373 
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To see how faithfully our KD-Rec_A375 model mimics in vivo processes observed in melanoma 374 
patients, we first compared the ~1500 DEGs identified between non-malignant and malignant cell 375 
types (all five), to those identified in our KD-Rec_A375 experiments (Figure 7A). We found that ~200 376 
genes overlapped between the two analyses in the opposite direction (Figure 7B), a significant 377 
enrichment over the random expectation (p-value <0.00001, see Methods).  378 
Importantly, the expression levels of MITF, APOE, and SPP1 (but not MAGEC2, and only 379 
modestly VIM) were also significantly depleted upon Rec knockdown in A375 cells, suggesting that 380 
the KD-Rec_A375 might recapitulate certain aspects of the melanoma process in patients (Figure 7C-381 
D). The affected MITF, APOE (Apolipoprotein E), and SPP1 (osteopontin, cytokine) highlight 382 
different aspects of melanoma progression, crosstalk of differentiation, angiogenesis [79] and 383 
inflammation [80], respectively. 384 
As MITF directly regulates HERV-K (via binding LTR5_Hs), we next focused on the MITF 385 
malignancy sub-cluster of the scRNA-seq dataset [78] (Figure 6B). We took the top 100 MITF-386 
correlated genes and determined their expression in our Rec-KD_A375 data. This approach revealed 387 
a highly significant (Wilcoxon-test, p-value < 2e16) reverse differential expression pattern between 388 
MITF-type malignancy and Rec-KD_A375 (Figure 7E), indicating an anti-correlation between the 389 
expression of MITF-target gene expression and Rec depletion. Thus, our KD-Rec_A375 model 390 
appears to recapitulate MITF-dependent aspects of melanoma in patients.  391 
4. Discussion 392 
HERV-K resembles "complex" retroviruses such as HIV-1 by its ability to encode multiple 393 
accessory proteins, including Rec, through alternative splicing of its Env transcript. While Env has 394 
the typical structure of a transmembrane protein (e.g., extracellular, transmembrane, cytoplasmic 395 
domains), Rec lacks the majority of the domains required for a membrane protein function (Figure 396 
8A). Still, it carries nuclear localization/export signals [3, 7]. Although Env and Rec are utterly 397 
different in sequence and function, our results suggest that Rec, like Env [39], exerts a modulatory 398 
effect on the EMT-like process in cancer progression. However, while Env affects signaling via 399 
ERK1/2 activation, through the cytoplasmic tail of the transmembrane Env protein [39], this domain 400 
is missing from Rec (Figure 8A). Rec, the splice variant of Env, inhibits the EMT-like process by 401 
affecting the expression levels of critical determinants of the EMT-like process, and certain upstream 402 
regulators. Thus, the two factors appear to act in the opposite direction. While Env overexpression 403 
(both RNA and protein) may promote tumor progression [39], depletion of Rec seems to result in a 404 
comparable phenotype. Curiously, similar to Env, the retroviral gene product, Gag also increases the 405 
tumorigenic potential of melanoma cells [38], raising the possibility that retroviral and accessory 406 
genes might generally act inversely, deciding on a long-lasting debate on the potential oncogenicity 407 
of a retroviral versus accessory genes of HERV-K. 408 
In about 50% of melanomas, the protein kinase BRAF is mutated (BRAFV600E) [84]. MITF is 409 
considered as a crucial regulator of melanoma invasiveness [85], and plays a critical role in controlling 410 
BRAFV600E melanoma [86, 87]. Accordingly, the expression of MITF has been widely used as a marker 411 
to distinguish between the proliferative and invasive types of melanoma cells [61, 85, 86, 88]. Reduced 412 
MITF expression generates invasive melanomas, with tumor-initiating properties [86]. Importantly, 413 
our KD-Rec_A375 in vitro system appears to recapitulate a subpopulation of melanoma cells (MITF 414 
malignancy) in human patients. Our data suggest that MITF activates LTR5_Hs only in melanoma 415 
(not in melanocytes), but Rec expression specifically marks the proliferative type of melanoma cells. 416 
Importantly, the proliferative phase of melanoma is still a better controllable stage of melanoma 417 
progression, by contrast to the invasive stage that gets frequently relapsed. If Rec expression is 418 
involved in maintaining a delicate balance between cell proliferation and invasion, as this study 419 
suggests, then Rec activation might be used as a sensitive marker to distinguish between the 420 
proliferative vs. invasive phenotypes of melanoma, not expressed in normal melanocytes. 421 
To control cell plasticity during melanomagenesis, the EMT-like network operates upstream of 422 
MITF. In cells harboring the SNAI2low/ZEB2low/ZEB1high phenotype, the depleted SNAI2 and ZEB2, 423 
expressed in normal melanocytes and function as tumor-suppressors, would fail to activate the MITF-424 
dependent melanocyte differentiation program [34, 87]. In parallel, the upregulated ZEB1 induces an 425 
invasion-associated cascade that operates in concert with downregulating MITF. 426 
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Our study reveals that depletion of Rec in a BRAFV600E mutant melanoma cells (A375) results in 427 
a decline in the MITF level. Thus, our KD-Rec_A375 cells suggest a model whereby a MITF-428 
dependent regulatory loop is disrupted through (i) decreased MITF binding to LTR5_Hs, which leads 429 
to (ii) reduced Rec levels and (iii) a further decline in MITF level, contributing to (iv) escalated tumor 430 
aggressiveness (Figure 8B). The observed cross-regulation between Rec and MITF reveals an 431 
inhibitory effect of Rec on the invasive transformation of melanoma. Our data suggest that a high 432 
level of Rec expression marks the proliferative (still controllable) state of melanoma cells, and opposes 433 
the molecular switch to the invasive state. Future research is required to decipher the exact 434 
mechanism of Rec control over MITF, and to test whether therapeutically induced Rec transcription, 435 
similar to enhanced MITF expression (e.g., PLX4032 treatment), results in a reversion of the invasive 436 
melanoma phenotype. 437 
Under healthy physiological conditions, only a limited number (n=18, or often less) of HERV-K 438 
loci appear to be active [13], whereas, in melanoma patients/cell lines, the number of transcribed 439 
HERV-K loci is higher (n~24) [28], indicating that specific HERV-K loci are transcribed only under 440 
pathologic conditions. Several loci express multiple HERV-K-derived products (both core and 441 
accessory replication factors). Although forced expression of MITF-M in non-malignant cells has been 442 
shown to enhance the levels of numerous HERV-K derived transcripts (e.g., Gag, Env, and Rec) [52], 443 
the activated HERV-K loci might differ in both intensities of expression and the composition of their 444 
HERV-K-derived transcripts. In line with this, HERV-K loci are variably activated and in various 445 
combinations in melanomas [28, 89], suggesting that variability in the amounts of expressed HERV-446 
K products might contribute to melanoma heterogeneity [22, 27], and possibly the progression and 447 
outcome of the disease. 448 
It has been widely discussed how precisely melanoma can be recapitulated in animal models. 449 
Interestingly, our analysis of single-cell transcriptome data from multiple human patients suggests a 450 
distinct separation of proliferative and invasive types of cells within a patient. In contrast, these two 451 
phases co-occur within the same melanoma cell in mice [88]  As Rec is hominid-specific, our study 452 
also has an evolutionary perspective that might explain certain species-specific features of melanoma 453 
progression in human patients, and help us to understand the limitation(s) of using animal models 454 
in melanoma studies. 455 
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Figure legends 456 
 457 
Figure 1. (A) Stacked barplots show the chromatin state (chromHMM) of the LTR5_Hs 458 
genomic loci (human Refseq genome) across 9 cell types. (B) Heatmap summarizing the 459 
transcription factor (TF) occupancy (ChIP-seq peaks, ENCODE) over individual LTR5_Hs 460 
loci in five human cell lines. This plot includes 234 out of 615 LTR5_Hs loci annotated in the 461 
human Refseq genome, which is occupied by at least one ChIP-seq peak. Each row 462 
represents an individual locus of LTR5_Hs. Each column shows TF ChIP-seq peak 463 
occupancy of a different cell line. Grey denotes the absence, whereas black is the presence 464 
of peaks in a given locus. Various TFs encompassing LTR5_Hs loci are manually annotated 465 
in a given cell line. The cluster of TFs binding over a subset of LTR5_Hs loci is shown in the 466 
red box. C. Line plots showing the distribution of normalized ChIP-seq tag counts of cMYC 467 
and NANOG in K562 and naive ESCs, respectively. The ChIP-seq tag counts are calculated 468 
relative to primed H1_ESCs, in a 3kb genomic window at the left boundaries of LTR5_Hs. 469 
(D) Characterizing primary melanoma cultures according to their MITF expression levels. 470 
Barplot is showing the level of MITF expression (Log2 TPM) in primary melanoma cultures 471 
(n=10). According to their MITF expression level, cultures are defined as proliferative 472 
melanoma (MITF-High) and invasive melanoma (MITF-Low) in vitro models. 473 
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 474 
Figure 2. (A) Barplot is showing the LTR5_Hs/HERV-K-int expression (Log2 CPM) levels 475 
in proliferative melanoma (MITF-High) and invasive melanoma (MITF-Low) cell lines 476 
(GSE60664). (B) A Scatter plot visualizes the average expression (Log2 CPM) (X-axis) and 477 
standard deviation from the mean (Y-axis) of transposable element (TE) families in various 478 
primary melanoma cultures (n=10). (C) Line plot showing the MITF ChIP-seq signal 479 
occupancy in proliferative melanoma (MITF-High) and invasive melanoma (MITF-Low) 480 
cell lines averaged over all of the LTR5_Hs loci. The identified E-Box motif in MITF bound 481 
LTR5_Hs in A375 cells is shown. Note that the E-box motif was found using the sequences 482 
of LTR5_Hs loci with MITF peaks. (D) The effect of PLX4032 treatment on MITF binding at 483 
LTR5_Hs loci. Upper panel: Line plot showing the MITF ChIP-seq signal averaged over 484 
LTR5_Hs loci in primary melanocytes and melanoma cells with and without the treatment 485 
of PLX4032. Lower panel: Heatmap of MITF ChIP-seq signals. Note: MITF occupies 486 
LTR5_Hs genomic loci upon PLX4032 treatment, specifically in melanoma, but not in 487 
melanocytes (over 100 loci). (E) Barplot is showing the number of MITF peaks detected over 488 
the genomic loci of various TE families in melanoma cells treated with PLX4032. This plot 489 
indicates only those families which have at least 5 peaks over the individual locus. 490 
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 491 
Figure 3. (A) Genome browser tracks showing the H3K27Ac, ATAC-seq, and MITF signals 492 
at a specific LTR5_Hs-HERVK locus (ERVK6, known to produce Rec) in MITF-High 493 
primary melanoma cultures and A375 cell line (proliferative) and MITF-low (invasive) 494 
melanoma primary cultures. (B) Normalized ATAC-seq (nucleosome-associated) signal 495 
averaged at LTR5_Hs genomic loci in A375 cells. (C) Normalized ChIP-seq signal of 496 
H3K4Me1 and H3K27Ac histone marks (corresponding to active chromatin states) 497 
averaged over LTR5_Hs genomic loci in A375 cells. (D) Knocking down (KD) Rec in A375 498 
and SKMEL-28 cells using RNA interference. Stable KD lines were selected in two-rounds 499 
by FACS sorting for the GFP-reporter signal. Barplots are showing the normalized RT-500 
qPCR quantification of Rec mRNA levels with three KD-Rec constructs. (E) Knocking down 501 
Rec affects the transcription of alternative HERV-K products. Barplot is showing the effect 502 
of knocking down Rec (KD-Rec) on the expression of alternative HERVK products, 503 
determined by real-time qPCR. Note: KD-Rec led to an increased level of Gag in SKMel-28 504 
(all the three biological replicates), whereas Env in A375 (KD1 only). (F) Knocking down 505 
Rec in A375 affects at least seven genomic HERV-K loci. Combined barplots showing the 506 
specificity of the RNAi strategy against the Rec subunit. Relative quantification of HERV-K 507 
Rec genomic loci compared with negative and scrambled controls indicates that all three 508 
KD constructs significantly affected at least 7 Rec expressing loci in A375 cells. 509 
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 510 
Figure 4. (A) Barplots of significant Gene Ontology (GO) Biological Process terms 511 
enrichment analysis of DEGs in KD-Rec_A375. Values are negative logarithms of the 512 
corrected p-values (Benjamini Hochberg FDR). (B) Barplots representing means ± SEM from 513 
RNA-seq expression values (Log2 TPM) for selected DEGs in KD-Rec_A375 (e.g., Matrix 514 
metallopeptidase 2 (MMP2), a classical marker of invasion; N-Cadherin (CDH2), Zinc 515 
finger protein SNAI2 (SNAI2), Forkhead box C2 (FOXC2) and Goosecoid Homeobox (GSC) 516 
are among the vital gene regulators of the canonical EMT transition. (C) Barplots 517 
representing means ± SEM from RNA-seq expression values (Log2 TPM) for DEGs in KD-518 
Rec_A375 vs. control, involved in the EMT-like process in melanoma [34] (e.g., SNAI2, 519 
ZEB2, and ZEB1). (D) Barplots representing means ± SEM from RNA-seq expression values 520 
(Log2 TPM) for selected DEGs in KD-Rec_A375 vs. control, known as inducers of the EMT-521 
like process (e.g., WNT5A and GSK3B) and SPANXC (sperm protein associated with the 522 
nucleus in the X chromosome). (E) Barplots are showing the effect of knocking down Rec 523 
in A375 vs. control on SPANXB1/B2 genes, detected as DEG in RNA-seq experiments, and 524 
validated using real-time qPCR. 525 
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 526 
Figure 5. (A) Quantifications transcriptional variation of MITF-M by KD-Rec in A375 cells 527 
using RNA-seq and by real-time qPCR. (B) Barplot representing means ± SEM from RNA-528 
seq expression values (Log2 TPM) for melanocyte markers (e.g., TYR and PMEL) upon Rec-529 
KD in A375. (C) Representative inverted light microscope images of trans-well invasion 530 
assay performed in A375 melanoma cells upon knocking-down Rec by three KD constructs 531 
(KD1-3). UT, untransfected control. Scale bars, 400 µm. (D) Quantification of cells invading 532 
in the trans-well invasion assay (C). ImageJ counted the number of invaded cells. Columns 533 
indicate the average number of invaded cells per field from two independent experiments. 534 
Error bars represent the means±s.d. of two independent experiments. Mann Whitney test; 535 
**P ≤ 0.01, ****p ≤ 0.0001 (See methods for details). 536 
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 537 
Figure 6. (A) Various plots with a maximum of thirteen distinct clusters are visualized on 538 
UMAP coordinates using 10XGenomics scRNA-seq [78] and their original annotations. The 539 
left panel shows the Malignant and Non-Malignant cell populations, whereas the right 540 
panel is displaying all the clusters obtained that were classified using their original 541 
annotations. (B) Feature plots based on the UMAP plot shown on (A) visualizing the 542 
expression of selected markers used to identify the distinct cell-types in the melanoma 543 
population. The color intensity gradient indicates the expression of the depicted marker 544 
gene. Each dot represents an individual cell. Dots in green denote lower, whereas in dark 545 
red, a higher level of gene expression in a given single cell. This resulted in five distinct 546 
malignant cell types, marked by MAGEC2, MITF, APOE, and Ki67, respectively (See Fig. 547 
7A for SPP1 expression). 548 
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 549 
Figure 7. (A) Heatmap visualization of scaled expression [log TPM (transcripts per million)] 550 
values of a distinctive set of ~ 1500 genes (log2 fold change > one and > 50% of cells 551 
expressing either in healthy or malignant cells), which are differentially expressed in 552 
scRNA-seq data. Colour scheme is based on Z-score distribution from -2.5 (gold) to 2.5 553 
(purple). Left margin color bars highlight representative gene sets specific to the respective 554 
clusters. (B) The Violin plot visualizes the density and distribution of expression (Log2 TPM 555 
values) of ~ 200 DEGs upon Rec-KD in A375 cells, which are common in the set of genes 556 
shown in the figure above (C). (p-value calculated by Wilcoxon test). (C) Violin plots 557 
visualize the density and distribution of expression of distinct marker genes for malignant 558 
melanoma clusters. (D) Barplots with +/- SEM show the down-regulation of MITF, SPP1, 559 
and APOE upon knockdown of Rec in A375 cells. (E) Violin plot showing the comparison 560 
of previously identified gene set as "MITF-high," consisting of MITF itself and the top 100 561 
genes correlated with MITF expression between malignant and non-malignant cells (blue) 562 
and upon Rec-KD in A375 by individual shRNA constructs (gold). (p-value calculated by 563 
Wilcoxon test). 564 
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 565 
 566 
Figure 8. (A) Schematic structure of the HERV-K-derived alternative splice products, Env 567 
and Rec, and their effect on the endothelial-mesenchymal transition (EMT)-like process of 568 
cancer progression (EMT(L). The signal peptide (SP); transmembrane subunit (TM); Splice 569 
acceptor (Sa); Splice donor (Sd). (B) Modeling the interaction loop between MITF and 570 
LTR5_Hs and Rec in melanoma. MITF binds to LTR5_Hs and drives Rec expression. Rec 571 
marks the proliferative stage melanoma cells and, similarly to MITF, inhibits the 572 
endothelial-mesenchymal transition (EMT)-like process (EMT(L). Depletion of Rec results 573 
in MITF downregulation and the failure to maintain the balance between cell proliferation 574 
and invasion. 575 
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 576 
Figure S1. (A) (Left panel) Ranked correlation matrix of genes and 42 transposable elements 577 
(TE) families, which are differentially expressed between proliferative and invasive 578 
primary melanoma cultures. Genes and TE families are manually annotated. Color codes 579 
on the left side represent the unsupervised clusters of most variable genes and TEs across 580 
the samples. On the right panel, selected genes are listed that are positively or negatively 581 
correlated with LTR5_Hs expression across the melanoma primary cultures. (B) 582 
Distribution of ChIP-seq signal of the H3K4Me3 histone mark occupancy, corresponding to 583 
active promoters averaged over LTR5_Hs loci in MITF-High (proliferative) vs. MITF-Low 584 
(invasive) state of primary melanoma cultures. (C) Distribution of ChIP-seq signal of the 585 
H3K27Ac histone mark occupancy (lower panel) averaged over LTR5_Hs loci in MITF-586 
High (proliferative) vs. MITF-Low (invasive) state of primary melanoma cultures. (D) 587 
Heatmap displays the DEGs upon KD-Rec in A375 cells. 588 
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